Nutanix, Cyxtera Partner To Launch First Nutanix Federal Innovation Lab, No Terms Disclosed
Nutanix (NASDAQ: NTNX), a leader in hybrid and multicloud computing, and
85 Biggest Movers From Yesterday
Gainers
Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy adult volunteers.